Dr. Andreu Soldevila

Leanbio is a market oriented CDMO that develops and manufactures biopharmaceutical products as New biological entities and Biosimilars, applying “Lean bioproduction” through tailored quality by design and ICH compliant approach in order to maximize project success, minimize time to market, costs and risks. Leanbio follows a knowledge-based strategy, applying cutting edge technological platforms and working altogether with customers through the different stages of development across project lifecycle: Platform development Specific development Process characterization Scale-up Manufacture Leanbio covers full value chain of services in the development and manufacture of biotherapeutics from gene to vial.